GE HealthCare Technologies (NASDAQ:GEHC) Shares Gap Up - Still a Buy?

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report)'s stock price gapped up before the market opened on Friday . The stock had previously closed at $67.05, but opened at $69.00. GE HealthCare Technologies shares last traded at $69.59, with a volume of 1,155,783 shares changing hands.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on GEHC. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $96.50.

GE HealthCare Technologies Stock Up 0.0 %

The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The stock has a market capitalization of $31.17 billion, a price-to-earnings ratio of 15.73, a PEG ratio of 3.19 and a beta of 1.14. The business has a fifty day moving average of $76.10 and a 200 day moving average of $81.91.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.21%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.23%.

Institutional Investors Weigh In On GE HealthCare Technologies

Hedge funds and other institutional investors have recently bought and sold shares of the business. CoreFirst Bank & Trust acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at $25,000. Runnymede Capital Advisors Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at $28,000. Stonebridge Financial Group LLC boosted its position in shares of GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after buying an additional 222 shares during the period. LGT Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 46.2% during the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after purchasing an additional 123 shares in the last quarter. Finally, Accredited Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at about $30,000. Institutional investors and hedge funds own 82.06% of the company's stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.